Non-confirmation of anthelmintic resistance in Ostertagia spp
1Palmerston North Animal Health Laboratory, P.O. Box 1654, Palmerston North.
New Zealand Veterinary Journal
|August 1, 1986
Abstract:
An investigation was undertaken to confirm the existence of a mebendazole-resistant strain of Ostertagia spp. on a ram-breeding property in Taihape. The results indicated that while a strain of Haemonchus contortus from this farm was highly resistant to mebendazole, an isolate of Ostertagia spp. was fully susceptible. Possible reasons for the discrepancy between previous and present findings are briefly discussed.
Related Concept Videos
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...